THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY;EIGER BIOPHARMACEUTICALS INC.
发明人:
申请号：
IL26656819
公开号：
IL266568D0
申请日:
2019.05.12
申请国别(地区):
IL
年份:
2019
代理人:
摘要：
Provided herein are liquid pharmaceutical formulations comprising exendin (9-39) or a pharmaceutically acceptable salt thereof and a tonicity modifier in a physiologically acceptable buffer having a pH in the range of about 5 to about 6. In some embodiments, the liquid pharmaceutical formulation comprises exendin (9-39) or a pharmaceutically acceptable salt thereof in an acetate buffer or a citrate buffer. Methods of treating or preventing hyperinsulinemic hypoglycemia in a subject comprising administering to the subject the liquid pharmaceutical formulation are also provided.
